Lactopeptides and human blood pressure

Current Opinion in Lipidology

Volumn 21, Issue 1, 2010, Pages 58-63

  Geleijnse, Johanna M ^a   Engberink, Marielle F ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

ACE; Angiotensin converting enzyme; Bioactive peptides; Blood pressure; Human, hypertension; IPP; Lactopeptides; Lactotripeptides; VPP

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ISOLEUCINE; ISOLEUCINE PRO PRO PLUS VAL PRO PRO; LACTOPEPTIDE; PEPTIDE; PLACEBO; PROLINE; UNCLASSIFIED DRUG; VALINE;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DRUG EFFECT; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; META ANALYSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; HUMANS; MILK PROTEINS; PEPTIDES;

EID: 77649104501     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283333813     Document Type: Review

References (39)

1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
2. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
3. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
4. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-1536.
5. Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47:296-308.
6. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. J Am Med Assoc 2002; 288:1882-1888.
7. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117-1124.
8. Alonso A, Beunza JJ, Delgado-Rodriguez M, et al. Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 2005; 82:972-979.
9. Engberink MF, Hendriksen MA, Schouten EG, et al. Inverse association between dairy intake and hypertension: the Rotterdam Study. Am J Clin Nutr 2009; 89:1877-1883.
10. Massey LK. Dairy food consumption, blood pressure and stroke. J Nutr 2001; 131:1875-1878.
11. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 2003; 17:471-480.
12. van Mierlo LA, Arends LR, Streppel MT, et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006; 20:571-580.
13. Foltz M, Meynen EE, Bianco V, et al. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 2007; 137:953-958.
14. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996; 126:3063-3068.
15. Satake M, Enjoh M, Nakamura Y, et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem 2002; 66:378-384.
16. Erdmann K, Cheung BW, Schroder H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 2008; 19:643-654.
17. Hartmann R, Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol 2007; 18:163-169.
18. Nakamura Y, Masuda O, Takano T. Decrease of tissue angiotensin I-convert-ing enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotechnol Biochem 1996; 60:488-489.
19. Boelsma E, Kloek J. Lactotripeptides and antihypertensive effects: a critical review. Br J Nutr 2009; 101:776-786.
20. Jauhiainen T, Korpela R. Milk peptides and blood pressure. J Nutr 2007; 137 (3 Suppl 2):825S-829S.
21. Pripp AH. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res 2008; 52. doi:10.3402/fnr.v52i0.1641.
22. Usinger L, Ibsen H, Jensen LT. Does fermented milk possess antihypertensive effect in humans? J Hypertens 2009; 27:1115-1120.
23. Xu JY, Qin LQ, Wang PY, et al. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008; 24:933-940.
24. Aihara K, Kajimoto O, Hirata H, et al. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005; 24:257-265.
25. Jauhiainen T, Vapaatalo H, Poussa T, et al. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005; 18 (12 Pt 1):1600-1605.
26. HataY, YamamotoM,Ohni M, et al. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64:767-771.
27. Mizushima S, Ohshige K, Watanabe J, et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 2004; 17:701-706.
28. Seppo L, Suomalainen T, Korpela R. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension: a pilot study on humans. Milch-wissenchaft 2002; 57:124-127.
29. Tuomilehto J, Lindstrom J, Hyyrynen J, et al. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens 2004; 18:795-802.
30. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-l owering effect in hypertensive subjects. Am J Clin Nutr 2003; 77:326-330.
31. EngberinkMF, Schouten EG, KokFJ, et al. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension 2008; 51:399-405.
32. van der Zander K, Jakel M, Bianco V, Koning MM. Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. J Hum Hypertens 2008; 22:804-806.
33. van der Zander K, Bots ML, Bak AA, et al. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am J Clin Nutr 2008; 88:1697-1702.
34. van Mierlo LA, Koning MM, van der Zander K, Draijer R. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr 2009; 89:617-623.
35. de Leeuw PW, van der Zander K, Kroon AA, et al. Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press 2009; 18:44-50.
36. Mizuno S, Matsuura K, Gotou T, et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 2005; 94:84-91. (Pubitemid 41357814)
37. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr 2000; 84 (Suppl 1):S33-S37.
38. Yade R (editor). Proteins in food processing. CRC Press: Woodhead Publishing in Food Science and Technology, Boca Raton, UK; 2004.
39. Wuerzner G, Peyrard S, Blanchard A, et al. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. J Hypertens 2009; 27:1404-1409.